Free Trial

Boston Partners Sells 112,506 Shares of The Pennant Group, Inc. (NASDAQ:PNTG)

Boston Partners trimmed its position in The Pennant Group, Inc. (NASDAQ:PNTG - Free Report) by 52.8% during the fourth quarter, according to its most recent 13F filing with the SEC. The fund owned 100,391 shares of the company's stock after selling 112,506 shares during the period. Boston Partners owned about 0.34% of The Pennant Group worth $1,398,000 as of its most recent filing with the SEC.

Other institutional investors and hedge funds also recently made changes to their positions in the company. Paradigm Capital Management Inc. NY grew its holdings in The Pennant Group by 79.1% during the 3rd quarter. Paradigm Capital Management Inc. NY now owns 1,196,500 shares of the company's stock worth $13,317,000 after acquiring an additional 528,612 shares during the period. Kent Lake Capital LLC lifted its stake in The Pennant Group by 34.6% in the third quarter. Kent Lake Capital LLC now owns 583,631 shares of the company's stock valued at $6,496,000 after buying an additional 150,187 shares during the period. First Eagle Investment Management LLC boosted its holdings in The Pennant Group by 16.7% during the third quarter. First Eagle Investment Management LLC now owns 397,900 shares of the company's stock worth $4,429,000 after buying an additional 56,893 shares during the last quarter. GSA Capital Partners LLP grew its position in shares of The Pennant Group by 71.2% during the 3rd quarter. GSA Capital Partners LLP now owns 118,101 shares of the company's stock worth $1,314,000 after buying an additional 49,114 shares during the period. Finally, Cornercap Investment Counsel Inc. bought a new stake in shares of The Pennant Group in the 4th quarter valued at about $596,000. Institutional investors own 85.88% of the company's stock.


The Pennant Group Stock Up 2.7 %

Shares of NASDAQ:PNTG traded up $0.61 during midday trading on Friday, reaching $23.02. 157,416 shares of the company were exchanged, compared to its average volume of 207,296. The firm has a market cap of $691.75 million, a PE ratio of 42.63, a P/E/G ratio of 2.35 and a beta of 2.01. The company has a quick ratio of 1.16, a current ratio of 1.16 and a debt-to-equity ratio of 0.51. The Pennant Group, Inc. has a fifty-two week low of $10.31 and a fifty-two week high of $23.57. The stock has a fifty day simple moving average of $20.55 and a two-hundred day simple moving average of $16.80.

The Pennant Group (NASDAQ:PNTG - Get Free Report) last posted its quarterly earnings data on Wednesday, February 28th. The company reported $0.18 earnings per share for the quarter, missing the consensus estimate of $0.19 by ($0.01). The firm had revenue of $145.95 million for the quarter, compared to analyst estimates of $136.79 million. The Pennant Group had a return on equity of 13.42% and a net margin of 2.86%. During the same period in the prior year, the company earned $0.15 earnings per share. As a group, sell-side analysts forecast that The Pennant Group, Inc. will post 0.73 earnings per share for the current year.

Wall Street Analysts Forecast Growth

Several research analysts recently weighed in on the stock. Stephens reissued an "overweight" rating and set a $23.00 price objective on shares of The Pennant Group in a research note on Tuesday, May 7th. Truist Financial boosted their price target on shares of The Pennant Group from $22.00 to $25.00 and gave the company a "hold" rating in a report on Wednesday. Oppenheimer raised their price objective on The Pennant Group from $18.00 to $22.00 and gave the stock an "outperform" rating in a research note on Friday, March 1st. Finally, Royal Bank of Canada boosted their target price on The Pennant Group from $21.00 to $26.00 and gave the company an "outperform" rating in a research note on Thursday, May 9th.

View Our Latest Research Report on PNTG

About The Pennant Group

(Free Report)

The Pennant Group, Inc provides healthcare services in the United States. It operates in two segments, Home Health and Hospice Services, and Senior Living Services. The company offers home health services, including clinical services, such as nursing, speech, occupational and physical therapy, medical social work, and home health aide services; and hospice services comprising clinical care, education, and counseling services for the physical, spiritual, and psychosocial needs of terminally ill patients and their families.

Featured Stories

Institutional Ownership by Quarter for The Pennant Group (NASDAQ:PNTG)

Should you invest $1,000 in The Pennant Group right now?

Before you consider The Pennant Group, you'll want to hear this.

MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and The Pennant Group wasn't on the list.

While The Pennant Group currently has a "Moderate Buy" rating among analysts, top-rated analysts believe these five stocks are better buys.

View The Five Stocks Here

7 Stocks to Buy And Hold Forever Cover

Click the link below and we'll send you MarketBeat's list of seven stocks and why their long-term outlooks are very promising.

Get This Free Report

Featured Articles and Offers

Search Headlines: